Evidence map›Paper›PMID 38787074›Full record

ArticleToxins2024

Pulmonary Thromboembolism following Russell's Viper Bites.

Subramanian Senthilkumaran, Sasikumar Sampath, José R Almeida, Jarred Williams, Harry F Williams, Ketan Patel, Ponniah Thirumalaikolundusubramanian, Sakthivel Vaiyapuri

Abstract readCase Reports
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Subramanian SenthilkumaranManian Medical Centre, Erode 638001, India.ORCID 0000-0001-5262-8367
Sasikumar SampathPrimary Health Care Corporation, Doha 26555, Qatar.
José R AlmeidaSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-4637-4468
Jarred WilliamsSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-4647-1399
Harry F WilliamsToxiven Biotech Private Limited, Coimbatore 641042, India.ORCID 0000-0001-5095-3131
Ketan PatelSchool of Biological Sciences, University of Reading, Reading RG6 6UB, UK.
Ponniah ThirumalaikolundusubramanianThe Tamil Nadu Dr M.G.R Medical University, Chennai 600032, India.ORCID 0000-0003-1814-8743
Sakthivel VaiyapuriSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-6006-6517

Funding

Medical Research Council ITTP PhD StudentshipMedical Research Council MR/W019353/1
6 · The paper itself

Abstract

Snakebite envenoming and its resulting complications are serious threats to the health of vulnerable people living in rural areas of developing countries. The knowledge of the heterogeneity of symptoms associated with snakebite envenoming and their management strategies is vital to treat such life-threatening complications to save lives. Russell's viper envenomation induces a diverse range of clinical manifestations from commonly recognised haemotoxic and local effects to several rare conditions that are often not reported. The lack of awareness about these unusual manifestations can affect prompt diagnosis, appropriate therapeutic approaches, and positive outcomes for patients. Here, we report pulmonary thromboembolism that developed in three patients following Russell's viper envenomation and demonstrate their common clinical features and diagnostic and therapeutic approaches used. All patients showed clinical signs of local (oedema) and systemic (blood coagulation disturbances) envenomation, which were treated using polyvalent antivenom. They exhibited elevated heart rates, breathlessness, and reduced oxygen saturation, which are non-specific but core parameters in the diagnosis of pulmonary embolism. The recognition of pulmonary embolism was also achieved by an electrocardiogram, which showed sinus tachycardia and computed tomography and echocardiogram scans further confirmed this condition. Anti-coagulant treatment using low-molecular-weight heparin offered clinical benefits in these patients. In summary, this report reinforces the broad spectrum of previously unreported consequences of Russell's viper envenomation. The constant updating of healthcare professionals and the dissemination of major lessons learned in the clinical management of snakebite envenoming through scientific documentation and educational programs are necessary to mitigate the adverse impacts of venomous snakebites in vulnerable communities.

Indexed as

AntiveninsDaboiaPulmonary EmbolismSnake BitesAdultAnimalsAnticoagulantsFemaleHumansMaleMiddle AgedViper VenomsAnticoagulantsAntiveninsViper Venomsanticoagulant therapyCT pulmonary angiographyD-dimersechocardiogrampulmonary embolismRussell’s vipersnakebite envenomingthrombosis

Identifiers

PMID38787074
PMCPMC11125611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.